Fock KM, Talley N, Hunt R, et al. Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol. 2004 Apr;19(4):357-367. PMID: 15012771
DeVault KR, Castell DO, American College of Gastroenterology. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005 Jan;100(1):190-200. PMID: 15654800
Dent J, Jones R, Kahrilas P, et al. Management of gastro-esophageal reflux disease in general practice. BMJ. 2001 Feb;322(7282):344-347. PMID: 11159660
Armstrong D, Marshall JK, Chiba N, et al. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004. Can J Gastroenterol. 2005 Jan;19(1):15-35. PMID: 15685294
Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013 Mar;108(3):308-328. http://gi.org/guideline/diagnosis-and-managemen-of-gastroesophageal-reflux-disease/. Accessed 18 Jul 2013. PMID: 23419381
Vakil N, van Zanten SV, Kahrilas P, et al; Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006 Aug;101(8):1900-1920. PMID: 16928254
Pharmacy Benefits Management Strategic Healthcare Group and the Medical Advisory Panel Veterans Health Administration Department of Veterans Affairs. VHA/DoD clinical practice guideline for the management of adults with gastroesophageal reflux disease in primary care practice. http://www.guideline.gov/. Mar 2003.
New Zealand Guidelines Group. Management of dyspepsia and heartburn: evidence-based practice guideline. Ministry of Health. http://www.health.govt.nz/. Jun 2004.
Poh J. Restrictions on the use of metoclopramide-containing products. Health Sciences Authority (HSA). http://www.hsa.gov.sg. 21 Sep 2016. Accessed 14 Mar 2019.
Sollano JD, Romano RP, Ibanez-Guzman L, et al. Clinical practice guidelines on the diagnosis and treatment of gastroesophageal reflux disease (GERD). Philippine Journal of Internal Medicine. 2015 Jul-Sep;53(3):1-17. http://www.pcp.org.ph/. Accessed 02 Oct 2015
Hunt R, Armstrong D, Katelaris P, et al. GERD. Global perspective on gastroesophageal reflux disease. World Gastroenterology Organisation (WGO). http://www.worldgastroenterology.org/. Oct 2015. Accessed 06 May 2016.
Iwakiri K, Kinoshita Y, Habu Y, et al. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015. J Gastroenterol. 2016 Aug;51(8):751-767. doi: 10.1007/s00535-016-1227-8. PMID: 27325300
Tack J, Camilleri M, Chang L, et al. Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther. 2012 Apr;35(7):745-767. doi: 10.1111/j.1365-2036.2012.05011.x. PMID: 22356640
Wiśniowska B, Tylutki Z, Wyszogrodzka G, et al. Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials. BMC Pharmacol Toxicol. 2016 Mar 10;17:12. doi: 10.1186/s40360-016-0053-1. Accessed 27 Dec 2016. PMID: 26960809
Wolfe MM. Overview and comparison of the proton pump inhibitors for the treatment of acid-related disorders. UpToDate. https://www.uptodate.com/. 02 Jun 2016. Accessed 27 Dec 2016.
Fock KM, Talley N, Goh KL, et al. Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus. Gut. 2016 Sep;65(9):1402-1415. doi: 10.1136/gutjnl-2016-311715. Accessed 29 May 2017. PMID: 27261337
Hunt R, Armstrong D, Katelaris P, et al. World Gastroenterology Organisation global guidelines: GERD global perspective on gastroesophageal reflux disease. J Clin Gastroenterol. 2017 Jul;51(6):467-478. doi: 10.1097/MCG.0000000000000854. Accessed 24 Jan 2018. PMID: 28591069
Koop H. Medical therapy of gastroesophageal reflux disease beyond proton pump inhibitors: where are we heading?. Visc Med. 2018 Apr;34(2):110-115. doi: 10.1159/000486692. Accessed 07 Jan 2019. PMID: 29888239
Niikura R, Yamada A, Hirata Y, et al. Efficacy of vonoprazan for gastroesophageal reflux symptoms in patients with proton pump inhibitor-resistant non-erosive reflux disease. Intern Med. 2018 Sep;57(17):2443-2450. doi: 10.2169/internalmedicine.0492-17. Accessed 07 Jan 2019. PMID: 29607951
Oshima T, Miwa H. Potent potassium-competitive acid blockers: a new era for the treatment of acid-related dieases. J Neurogastroenterol Motil. 2018 Jul;24(3):334-344. doi: 10.1056/jnm18029. Accessed 07 Jan 2019. PMID: 29739175
Shinozaki S, Osawa H, Hayashi Y, et al. Vonoprazan 10 mg daily is effective for the treatment of patients with proton pump inhibitor-resistant gastroesophageal reflux disease. Biomed Rep. 2017 Sep;7(3):231-235. doi: 10.3892/br.2017.947. Accessed 07 Jan 2019. PMID: 28894571
Vakil NB. Antiulcer medications: mechanism of action, pharmacology, and side effects. UpToDate. http://www.uptodate.com. 22 May 2018. Accessed 13 Dec 2018.
MacFarlane B. Management of gastroesophageal reflux disease in adults: a pharmacist's perspective. Integr Pharm Res Pract. 2018 Jun;7:41-52. doi: 10.2147/IPRP.S142932. Accessed 19 Feb 2019. PMID: 29892570
Sandhu DS, Fass R. Current trends in the management of gastroesophageal reflux disease. Gut Liver. 2018 Jan;12(1):7-16. doi: 10.5009/gnl16615. Accessed 12 Feb 2019. PMID: 28427116
Hojo M, Nagahara A, Hahm KB, et al. Management of gastroesophageal reflux disease in Asian countries: Results of a questionnaire survey. Digestion. 2020;101(1):66-79. doi: 10.1159/000504749. Accessed 05 Feb 2020. PMID: 31801133
Young A, Kumar MA, Thota PN. GERD: a practical approach. Cleve Clin J Med. 2020 Apr;87(4):223-230. doi: 10.3949/ccjm.87a.19114. PMID: 32238378
Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon consensus. Gut. 2018 Jul;67(7):1351-1362. doi: 10.1136/gutjnl-2017-314722. Accessed 21 Feb 2019. PMID: 29437910
Kahrilas PJ, Shaheen NJ, Vaezi MF. American Gastroenterological Association Institute Technical Review on the management of gastroesophageal reflux disease. Gastroenterology. 2008 Oct;135(4):1392-1413. doi: 10.1053/j.gastro.2008.08.044. Accessed 20 Feb 2019. PMID: 18801365
Kahrilas PJ, Shaheen NJ, Vaezi MF. American Gastroenterological Association medical position statement on the management of gastroesophageal reflux disease. 2008 Oct;135(4):1383-1391, 1391. e1-5. doi: 10.1053/j.gastro.2008.08.045. Accessed 12 Feb 2019. PMID: 18789939
Richter JE, Friedenberg FK. Gastroesophageal reflux disease. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. 10th ed. Philadelphia, PA: Saunders, Elsevier; 2016. 733-754. :733-754.
Fass R. Approach to refractory gastroesophageal reflux disease in adults. UpToDate. https://www.uptodate.com. 14 May 2024. Accessed 21 Jun 2023.
Kahrilas PJ. Clinical manifestations and diagnosis of gastroesophageal reflux in adults. UpToDate. https://www.uptodate.com/. 15 Jul 2022.
Kahrilas PJ. Medical management of gastroesophageal reflux disease in adults. UpToDate. https://www.uptodate.com/. 19 Sep 2022.
Katz PO, Dunbar KB, Schnoll-Sussman FH, et al. ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2022 Jan;117(1):27-56. doi: 10.14309/ajg.0000000000001538. PMID: 34807007
Maneerattanaporn M, Pittayanon R, Patcharatrakul T, et al. Thailand guideline 2020 for medical management of gastroesophageal reflux disease. J Gastroenterol Hepatol. 2022 Apr;37(4):632-643. doi: 10.1111/jgh.15758. Accessed 09 Nov 2023. PMID: 34907597
Mori H, Suzuki H. Role of acid suppression in acid-related diseases: proton pump inhibitor and potassium-competitive acid blocker. J Neurogastroenterol Motil. 2019 Jan 31;25(1):6-14. doi: 10.5056/jnm18139. PMID: 30504527
ASGE Standards of Practice Committee; Desai M, Ruan W, Thosani NC, et al. American Society for Gastrointestinal Endoscopy guideline on the diagnosis and management of GERD: methodology and review of evidence. Gastrointest Endosc. 2025 Feb;101(2):267-284. doi: 10.1016/j.gie.2024.10.008. PMID: 39692638
Chen JW, Vela MF, Peterson KA, et al. AGA clinical practice update on the diagnosis and management of extraesophageal gastroesophageal reflux disease: expert review. Clin Gastroenterol Hepatol. 2023 Jun;21(6):1414-1421. doi: 10.1016/j.cgh.2023.01.040. PMID: 37061897
Louie BE, Prakash N. Magnetic sphincter augmentation (MSA). UpToDate. https://www.uptodate.com. 15 Jan 2025.
Madisch A, Koop H, Miehlke S, et al. S2k guideline gastroesophageal reflux disease and eosinophilic esophagitis of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS). Gastroenterol. 2024 Oct;62(10):1786-1852. doi: 10.1055/a-2344-6282. PMID: 39389106
Schwaitzberg SD. Surgical treatment of gastroesophageal reflux in adults. UpToDate. https://www.uptodate.com. 27 Sep 2023.
Slater BJ, Collings A, Dirks R, et al. Multi-society consensus conference and guideline on the treatment of gastroesophageal reflux disease (GERD). Surg Endosc. 2023 Feb;37(2):781-806. doi: 10.1007/s00464-022-09817-3. PMID: 36529851
Triadafilopoulos G. Radiofrequency treatment for gastroesophageal reflux disease. UpToDate. https://www.uptodate.com. 14 Jul 2023.